Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells

International Journal of Cancer

Volumn 129, Issue 2, 2011, Pages 417-423

  Mego, Michal ^a,b   Giorgi, Ugo De ^a   Dawood, Shahenaah ^a   Wang, Xuemei ^b   Valero, Vicente ^a   Andreopoulou, Eleni ^a   Handy, Beverly ^a   Ueno, Naoto T ^a   Reuben, James M ^a   Cristofanilli, Massimo ^c  

^a UNIVERSITY OF TEXAS   (United States)

^b Faculty of Medicine of Comenius University and University Hospital Bratislava   (Slovakia)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Breast cancer; Circulating tumor cells; Prognostic factor

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER GRADING; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ASSAY; CIRCULATING TUMOR CELL; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; METASTASIS; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VISCERAL METASTASIS; BLOOD; BONE TUMOR; BRAIN TUMOR; BREAST TUMOR; FEMALE; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PROGNOSIS; TUMOR EMBOLISM;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79961118743     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25690     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96. (Pubitemid 351521864)
2. Swenerton KD, Legha SS, Smith T, Hortobagyi GN, Gehan EA, Yap HY, Gutterman JU, Blumenschein GR. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979;39: 1552-62. (Pubitemid 9172673)
3. Hortobagyi GN, Smith TL, Legha SS, Swenerton KD, Gehan EA, Yap HY, Buzdar AU, Blumenschein GR. Multivariate analysis of prognostic factors in metastatic breast cancer. J Clin Oncol 1983;1:776-86. (Pubitemid 14167252)
4. Cardoso F, Di LA, Lohrisch C, Bernard C, Ferreira F, Piccart MJ. Second and subsequent lines of chemotherapy for metastatic breast cancer: What did we learn in the last two decades? Ann Oncol 2002; 13:197-207. (Pubitemid 34704970)
5. Hayes DF. Prognostic and predictive factors revisited. Breast 2005;14:493-9. (Pubitemid 41683571)
6. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351: 781-91. (Pubitemid 39095313)
7. Budd GT, Cristofanilli M, Ellis MJ, Stopeck A, Borden E, Miller MC, Matera J, Repollet M, Doyle GV, Terstappen LW, Hayes DF. Circulating tumor cells versus imagingpredicting overall survival in metastatic breast cancer. Clin Cancer Res 2006;12: 6403-9. (Pubitemid 44799711)
8. Dawood S, Broglio K, Valero V, Reuben J, Handy B, Islam R, Jackson S, Hortobagyi GN, Fritsche H, Cristofanilli M. Circulating tumor cells in metastatic breast cancer: From prognostic stratification to modification of the staging system? Cancer 2008;113:2422-30.
9. De Giorgi U, Valero V, Rohren E, Dawood S, Ueno NT, Miller MC, Doyle GV, Jackson S, Andreopoulou E, Handy BC, Reuben JM, Fritsche HA, et al. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer. J Clin Oncol 2009; 27:3303-11.
10. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, Krishnamurthy S, Ueno NT, et al. Circulating tumor cells in metastatic breast cancer: Biologic staging beyond tumor burden. Clin Breast Cancer 2007;7:471-9. (Pubitemid 46424284)
11. Reuben JM, Lee BN, Li C, Gao H, Broglio KR, Valero V, Jackson SA, Ueno NT, Krishnamurthy S, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and biomarkers: Implications for personalized targeted treatments for metastatic breast cancer. Breast J 2010;16:327-30.
12. Riethdorf S, Fritsche H, Müller V, Rau T, Schindlbeck C, Rack B, Janni W, Coith C, Beck K, Jänicke F, Jackson S, Gornet T, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: A validation study of the CellSearchTM system. Clin Cancer Res 2007;13:920-8. (Pubitemid 46340368)
13. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904. (Pubitemid 39383039)
14. Lang JE, Mosalpuria K, Cristofanilli M, Krishnamurthy S, Reuben J, Singh B, Bedrosian I, Meric-Bernstam F, Lucci A. HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer. Breast Cancer Res Treat 2009;113:501-7.
15. Yang J, Weinberg RA. Epithelialmesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-29. (Pubitemid 351757205)
16. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, et al. The epithelialmesenchymal transition generates cells with properties of stem cells. Cell 2008;133: 704-15. (Pubitemid 351636299)
17. Boogerd W, Vos VW, Hart AAM, Baris G. Brain metastasis in breast cancer; natural history, prognostic factors and outcome. J Neuro-Oncol 1993;15: 165-174. (Pubitemid 23136031)
18. De Giorgi U, Valero V, Rohren E, Mego M, Doyle GV, Miller MC, Ueno NT, Handy BC, Reuben JM, Macapinlac HA, Hortobagyi GN, Cristofanilli M. Circulating tumor cells and bone metastases as detected by FDG-PET/CT in patients with metastatic breast cancer. Ann Oncol 2010;21:33-9.
19. Slade MJ, Payne R, Riethdorf S, Ward B, Zaidi SA, Stebbing J, Palmieri C, Sinnett HD, Kulinskaya E, Pitfield T, McCormack RT, Pantel K, et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. Br J Cancer 2009;100: 160-6.
20. Fehm T, Müller V, Alix-Panabiéres C, Pantel K. Micrometastatic spread in breast cancer: Detection, molecular characterization and clinical relevance. Breast Cancer Res 2008;10 Suppl 1:S1.
21. Mego M, De Giorgi U, Hsu L, Ueno NT, Valero V, Jackson S, Andreopoulou E, Kau SW, Reuben JM, Cristofanilli M. Circulating tumor cells in metastatic inflammatory breast cancer. Ann Oncol 2009;20:1824-8.